US OptionsDetailed Quotes
IDYA241115P40000
- 10.18
- 0.000.00%
15min DelayClose Nov 12 16:00 ET
0.00High0.00Low
10.18Open10.18Pre Close0 Volume0 Open Interest40.00Strike Price0.00Turnover0.00%IV3.74%PremiumNov 15, 2024Expiry Date9.02Intrinsic Value100Multiplier2DDays to Expiry1.16Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.64Leverage Ratio--Theta--Rho--Eff Leverage--Vega
IDEAYA Biosciences Stock Discussion
IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen
The agreement grants IDEAYA an option for an exclusive worldwide license from Biocytogen for a potential first-in-class B7H3/PTK7 topo-I-payload BsADC program. B7H3/PTK7 has been found to be co-expressed in multiple solid tumor types, including double-digit percent prevalence in...
📊⚡️📊
The $Nasdaq Composite Index (.IXIC.US)$ rose 0.28% to close at 18403.74, and the $S&P 500 Index (.SPX.US)$ gained 0.10%. The $Dow Jones Industrial Average (.DJI.US)$ fell 0.08%, ending at...
2. $Inspire Veterinary Partners (IVP.US)$
3. $Dynatronics (DYNT.US)$
4. $Zapp Electric Vehicles (ZAPP.US)$
5. $Maxeon Solar Technologies (MAXN.US)$
6. $Grifols (GRFS.US)$
7. $SinglePoint (SING.US)$
8. $Venus Concept (VERO.US)$
9. $IDEAYA Biosciences (IDYA.US)$
10. $Kuke Music (KUKE.US)$
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...
No comment yet